These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37999877)

  • 61. Pathologic characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study.
    Tihan T; Ersen A; Qaddoumi I; Sughayer MA; Tolunay S; Al-Hussaini M; Phillips J; Gupta N; Goldhoff P; Baneerjee A
    Am J Surg Pathol; 2012 Jan; 36(1):43-55. PubMed ID: 21989351
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.
    Tomić TT; Olausson J; Wilzén A; Sabel M; Truvé K; Sjögren H; Dósa S; Tisell M; Lannering B; Enlund F; Martinsson T; Åman P; Abel F
    PLoS One; 2017; 12(4):e0175638. PubMed ID: 28448514
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review.
    Andrews LJ; Thornton ZA; Saincher SS; Yao IY; Dawson S; McGuinness LA; Jones HE; Jefferies S; Short SC; Cheng HY; McAleenan A; Higgins JPT; Kurian KM
    Neuro Oncol; 2022 Apr; 24(4):528-540. PubMed ID: 34718782
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations.
    Nakano Y; Yamasaki K; Sakamoto H; Matsusaka Y; Kunihiro N; Fukushima H; Inoue T; Honda-Kitahara M; Hara J; Yoshida A; Ichimura K
    Brain Tumor Pathol; 2019 Oct; 36(4):162-168. PubMed ID: 31254135
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Resection extent and BRAF V600E mutation status determine postoperative tumor growth velocity in pediatric low-grade glioma: results from a single-center cohort analysis.
    Gorodezki D; Zipfel J; Queudeville M; Sosa J; Holzer U; Kern J; Bevot A; Schittenhelm J; Nägele T; Ebinger M; Schuhmann MU
    J Neurooncol; 2022 Dec; 160(3):567-576. PubMed ID: 36319795
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.
    Yamada S; Kipp BR; Voss JS; Giannini C; Raghunathan A
    Am J Surg Pathol; 2016 Feb; 40(2):279-84. PubMed ID: 26414224
    [TBL] [Abstract][Full Text] [Related]  

  • 67. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
    Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
    Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas.
    Tabori U; Vukovic B; Zielenska M; Hawkins C; Braude I; Rutka J; Bouffet E; Squire J; Malkin D
    Neoplasia; 2006 Feb; 8(2):136-42. PubMed ID: 16611406
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss.
    Yeo YH; Byrne NP; Counelis GJ; Perry A
    Clin Neuropathol; 2013; 32(3):159-64. PubMed ID: 23196000
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The utility of DNA methylation analysis in elderly patients with pilocytic astrocytoma morphology.
    Suruga Y; Satomi K; Otani Y; Fujii K; Ishida J; Uneda A; Tsuboi N; Makino K; Hirano S; Kemmotsu N; Imoto R; Mizuta R; Tomita Y; Yasuhara T; Washio K; Yanai H; Matsushita Y; Hibiya Y; Yoshida A; Capper D; Ichimura K; Date I
    J Neurooncol; 2022 Oct; 160(1):179-189. PubMed ID: 36107362
    [TBL] [Abstract][Full Text] [Related]  

  • 71. BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.
    Suzuki Y; Takahashi-Fujigasaki J; Akasaki Y; Matsushima S; Mori R; Karagiozov K; Joki T; Ikeuchi S; Ikegami M; Manome Y; Murayama Y
    Brain Tumor Pathol; 2016 Jan; 33(1):40-9. PubMed ID: 26445861
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A case of high-grade astrocytoma with BRAF and ATRX mutations following a long-standing course over two decades.
    Nakata S; Horiguchi K; Ishiuchi S; Yoshimoto Y; Yamada S; Nobusawa S; Ikota H; Hirato J; Yokoo H
    Neuropathology; 2017 Aug; 37(4):351-357. PubMed ID: 28185325
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience.
    Colli SL; Cardoso N; Massone CA; Cores M; García Lombardi M; De Matteo EN; Lorenzetti MA; Preciado MV
    PLoS One; 2022; 17(4):e0266466. PubMed ID: 35363819
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Conditional reprogramming culture conditions facilitate growth of lower-grade glioma models.
    Yuan M; White D; Resar L; Bar E; Groves M; Cohen A; Jackson E; Bynum J; Rubens J; Mumm J; Chen L; Jiang L; Raabe E; Rodriguez FJ; Eberhart CG
    Neuro Oncol; 2021 May; 23(5):770-782. PubMed ID: 33258947
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spectrum of qualitative and quantitative imaging of pilomyxoid, intermediate pilomyxoid and pilocytic astrocytomas in relation to their genetic alterations.
    Fadel SA; von Reppert M; Kazarian E; Omay EZE; Marks A; Linder N; Hoffmann KT; Darbinyan A; Huttner A; Aboian MS
    Neuroradiology; 2023 Jan; 65(1):195-205. PubMed ID: 35984480
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin.
    Poore B; Yuan M; Arnold A; Price A; Alt J; Rubens JA; Slusher BS; Eberhart CG; Raabe EH
    Neuro Oncol; 2019 Feb; 21(2):252-263. PubMed ID: 30239952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The involvement of the MAPK pathway in pilocytic astrocytomas.
    Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
    Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice.
    Gronych J; Korshunov A; Bageritz J; Milde T; Jugold M; Hambardzumyan D; Remke M; Hartmann C; Witt H; Jones DT; Witt O; Heiland S; Bendszus M; Holland EC; Pfister S; Lichter P
    J Clin Invest; 2011 Apr; 121(4):1344-8. PubMed ID: 21403401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. NTRK2 gene fusions are uncommon in pilocytic astrocytoma.
    Moreno DA; Becker AP; Scapulatempo-Neto C; Menezes W; Sheren J; Walter AM; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
    Mol Biol Rep; 2022 Aug; 49(8):7567-7573. PubMed ID: 35713800
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma.
    Balasubramanian A; Gunjur A; Gan HK; Perchyonok Y; Cher LM
    J Clin Neurosci; 2020 Sep; 79():269-271. PubMed ID: 33070910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.